Jefferies Financial Group Portfolio holdings
Jefferies Financial Group is the investment banking and capital markets company that was known as Leucadia National until 2018, when it took the name of the bank it merged with in 2013. Leucadia traces back to Ian Cumming and Joseph Steinberg, Harvard Business School graduates who started out at the investment bank Carl Marks & Company and in 1979 took control of Talcott National, renaming it Leucadia the next year. As a holding company it bought and resold businesses, such as the insurer Colonial Penn, acquired in 1991 and sold in two pieces in 1997, and the telecoms company WilTel, acquired in 2003 and sold in 2005. Jefferies itself grew from a small equities trading shop into a full-service investment bank, and Richard Handler became chief executive of the combined company in 2013.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$204M |
| 2 |
SPDR Gold Trust
GLD
|
+$94.6M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$88.3M |
| 4 |
Intel
INTC
|
+$58.2M |
| 5 |
Boeing
BA
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$640M |
| 2 |
Apple
AAPL
|
+$234M |
| 3 |
Meta Platforms (Facebook)
META
|
+$128M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$114M |
| 5 |
PTC Therapeutics
PTCT
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.53% |
| 2 | Healthcare | 11.13% |
| 3 | Technology | 8.29% |
| 4 | Industrials | 4.73% |
| 5 | Financials | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$795B
| $903M | 6.69% |
1,184,500
-368,000
| -24% | -$280M |
2022 Q4
15 quarters
|
|
|
2
CALL
SPDR Gold Trust
GLD
$135B
| $898M | 6.65% |
2,358,900
+2,162,700
| +1,102% | +$846M |
2023 Q1
14 quarters
|
|
3
PUT
SpaceX
SPCX
$1.94T
| $773M | 5.73% |
5,126,600
+426,600
| +9% | +$59M |
2026 Q2
1 quarter
|
|
|
4
PUT
SPDR Gold Trust
GLD
$135B
| $552M | 4.09% |
1,450,200
+1,030,700
| +246% | +$403M |
2022 Q4
15 quarters
|
|
5
iShares Russell 2000 ETF
IWM
$77.7B
| $278M | 2.06% |
1,001,120
-262,012
| -21% | -$76.9M |
2022 Q4
15 quarters
|
|
6
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $262M | 1.94% |
1,662,500
-477,501
| -22% | -$75.4M |
2022 Q4
15 quarters
|
|
|
7
State Street SPDR S&P 500 ETF Trust
SPY
$795B
| $239M | 1.77% |
313,344
-841,962
| -73% | -$640M |
2022 Q4
15 quarters
|
|
8
PUT
Invesco QQQ Trust
QQQ
$459B
| $237M | 1.75% |
320,300
-129,700
| -29% | -$92.7M |
2022 Q4
15 quarters
|
|
|
9
Invesco QQQ Trust
QQQ
$459B
| $206M | 1.52% |
278,466
-53,671
| -16% | -$38.4M |
2022 Q4
15 quarters
|
|
|
10
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$18B
| $200M | 1.48% |
2,593,676
+2,570,870
| +11,273% | +$204M |
2025 Q4
3 quarters
|
|
11
CALL
Amazon
AMZN
$2.94T
| $165M | 1.22% |
662,700
+511,800
| +339% | +$130M |
2024 Q2
9 quarters
|
|
|
12
Amazon
AMZN
$2.94T
| $158M | 1.17% |
634,584
+100,664
| +19% | +$25.6M |
2022 Q4
15 quarters
|
|
13
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$48.5B
| $132M | 0.98% |
1,700,100
+1,450,100
| +580% | +$120M |
2024 Q4
7 quarters
|
|
14
Automatic Data Processing
ADP
$118B
| $124M | 0.92% |
480,010
-97,739
| -17% | -$25.9M |
2025 Q3
4 quarters
|
|
|
15
Berkshire Hathaway Class B
BRK.B
$1.23T
| $120M | 0.88% |
240,000
+175,115
| +270% | +$88.3M |
2024 Q2
9 quarters
|
|
16
Advanced Micro Devices
AMD
$868B
| $107M | 0.79% |
174,940
-108,566
| -38% | -$55.9M |
2022 Q4
15 quarters
|
|
17
Acadia Healthcare
ACHC
$3.56B
| $102M | 0.75% |
3,703,240
+98,173
| +3% | +$2.95M |
2025 Q4
3 quarters
|
|
|
18
SPDR Gold Trust
GLD
$135B
| $101M | 0.75% |
265,000
+241,893
| +1,047% | +$94.6M |
2022 Q4
15 quarters
|
|
|
19
PUT
Intel
INTC
$313B
| $100M | 0.74% |
835,200
+355,000
| +74% | +$36.2M |
2025 Q3
4 quarters
|
|
20
PUT
Broadcom
AVGO
$1.58T
| $94.4M | 0.7% |
268,900
+243,000
| +938% | +$91.5M |
2025 Q4
3 quarters
|
|
21
GRAIL Inc
GRAL
$5.64B
| $91.1M | 0.67% |
650,000
-74,000
| -10% | -$5.87M |
2026 Q1
2 quarters
|
|
|
22
PUT
GRAIL Inc
GRAL
$5.64B
| $91.1M | 0.67% |
650,000
| – | – |
2026 Q1
2 quarters
|
|
23
UroGen Pharma
URGN
$1.28B
| $89.4M | 0.66% |
2,199,652
| – | – |
2024 Q1
10 quarters
|
|
24
iShares Biotechnology ETF
IBB
$11.3B
| $87.9M | 0.65% |
417,500
+115,194
| +38% | +$23.1M |
2025 Q3
4 quarters
|
|
|
25
Intel
INTC
$313B
| $83.3M | 0.62% |
693,001
+570,588
| +466% | +$58.2M |
2022 Q4
15 quarters
|
|
Similar funds
Jefferies Financial Group's Q3 2026 Portfolio in Review
As of Q3 2026, Jefferies Financial Group held 1,968 positions worth $13.5B, down 11% from $15.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jefferies Financial Group withdrew a net $3.53B in Q3 2026, closing 703 positions and reducing 401 holdings. Its most notable exit was PTC Therapeutics, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 50% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jefferies Financial Group opened a new position in Emcor worth $40.1M.
- Jefferies Financial Group's largest Q3 2026 buy was Emcor: 53,175 shares worth $40.1M.
- Jefferies Financial Group added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2026, an estimated $204M increase.
- Jefferies Financial Group's biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $640M.
- Jefferies Financial Group fully exited PTC Therapeutics in Q3 2026, selling an estimated $111M.
- Jefferies Financial Group's ten largest holdings make up 34% of its $13.5B portfolio in Q3 2026.
- Jefferies Financial Group opened 337 new positions and closed 703 in Q3 2026.
- Jefferies Financial Group's portfolio value fell 11% quarter-over-quarter to $13.5B.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.